Omnicell, Inc. OMCL

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
56/100
Moderate

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems … Full OMCL analysis →

Competitive advantage assessment

Key strengths

  • Margins Stable Across Cycles Operating margin volatility is low (stability score 0.90), demonstrating pricing resilience across cycles.
  • Operating Expense Control OpEx growth is controlled (score 0.67), demonstrating operating leverage.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
51

Where OMCL ranks in Health Information Services

Omnicell, Inc. ranks #22 of 68 scored companies in Health Information Services by moat score — the top 32%. The widest moat in the group is Veeva Systems Inc. (VEEV) at 88/100.

Moat scores for companies ranked near OMCL in Health Information Services
# Company Moat score Rating
18 Privia Health Group, Inc. PRVA 60/100 Moderate
19 BrightSpring Health Services, I BTSG 60/100 Moderate
20 Premier, Inc. PINC 59/100 Moderate
21 10x Genomics, Inc. TXG 57/100 Moderate
22 Omnicell, Inc. OMCL 56/100 Moderate
23 Phreesia, Inc. PHR 56/100 Moderate
24 BrightSpring Health Services, I BTSGU 51/100 Moderate
25 Simulations Plus, Inc. SLP 51/100 Moderate
26 Talkspace, Inc. TALK 50/100 Moderate

See every General Corporate company ranked by moat score →

How OMCL scores on the Corporate Default defenses

Pricing Power

Score 51 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 70 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 64 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 48 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 62 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 42 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding OMCL's moat

What is Omnicell, Inc.'s moat score?

Omnicell, Inc. (OMCL) scores 56 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #22 of 68 scored companies in Health Information Services, the top 32%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 67 companies in Health Information Services. Its strongest defense is Cost Advantage (70/100) and its weakest is Scale & Market Position (42/100).

How does Omnicell, Inc. compare with other Health Information Services companies?

Omnicell, Inc. ranks #22 of 68 scored companies in Health Information Services by moat score. The widest moat in Health Information Services is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are 10x Genomics, Inc. (TXG) at 57 just above it and Phreesia, Inc. (PHR) at 56 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 67 companies in Health Information Services. The defenses are then weighted to produce the overall score out of 100.

Why is Omnicell, Inc. scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for Omnicell, Inc.?

The Corporate Default template measures 6 defenses, and OMCL scores: Pricing Power (51), Cost Advantage (70), Customer Stickiness (64), Capital Efficiency (48), Resilience (62), Scale & Market Position (42). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000